156 related articles for article (PubMed ID: 29211800)
1. Diagnostic test strategies in children at increased risk of inflammatory bowel disease in primary care.
Holtman GA; Lisman-van Leeuwen Y; Kollen BJ; Norbruis OF; Escher JC; Walhout LC; Kindermann A; de Rijke YB; van Rheenen PF; Berger MY
PLoS One; 2017; 12(12):e0189111. PubMed ID: 29211800
[TBL] [Abstract][Full Text] [Related]
2. Test Strategies to Predict Inflammatory Bowel Disease Among Children With Nonbloody Diarrhea.
Van de Vijver E; Heida A; Ioannou S; Van Biervliet S; Hummel T; Yuksel Z; Gonera-de Jong G; Schulenberg R; Muller Kobold A; Verkade HJ; van Rheenen PF;
Pediatrics; 2020 Aug; 146(2):. PubMed ID: 32694147
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic Accuracy of Fecal Calprotectin for Pediatric Inflammatory Bowel Disease in Primary Care: A Prospective Cohort Study.
Holtman GA; Lisman-van Leeuwen Y; Kollen BJ; Norbruis OF; Escher JC; Kindermann A; de Rijke YB; van Rheenen PF; Berger MY
Ann Fam Med; 2016 Sep; 14(5):437-45. PubMed ID: 27621160
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of point-of-care test calprotectin and lactoferrin for inflammatory bowel disease among children with chronic gastrointestinal symptoms.
Holtman GA; Lisman-van Leeuwen Y; van Rheenen PF; Kollen BJ; Escher JC; Kindermann A; de Rijke YB; Berger MY
Fam Pract; 2017 Aug; 34(4):400-406. PubMed ID: 27535331
[TBL] [Abstract][Full Text] [Related]
5. Fecal S100A12 and fecal calprotectin as noninvasive markers for inflammatory bowel disease in children.
Sidler MA; Leach ST; Day AS
Inflamm Bowel Dis; 2008 Mar; 14(3):359-66. PubMed ID: 18050298
[TBL] [Abstract][Full Text] [Related]
6. Use of Laboratory Markers in Addition to Symptoms for Diagnosis of Inflammatory Bowel Disease in Children: A Meta-analysis of Individual Patient Data.
Holtman GA; Lisman-van Leeuwen Y; Day AS; Fagerberg UL; Henderson P; Leach ST; Perminow G; Mack D; van Rheenen PF; van de Vijver E; Wilson DC; Reitsma JB; Berger MY
JAMA Pediatr; 2017 Oct; 171(10):984-991. PubMed ID: 28806445
[TBL] [Abstract][Full Text] [Related]
7. Safely ruling out inflammatory bowel disease in children and teenagers without referral for endoscopy.
Van de Vijver E; Schreuder AB; Cnossen WR; Muller Kobold AC; van Rheenen PF;
Arch Dis Child; 2012 Dec; 97(12):1014-8. PubMed ID: 23019289
[TBL] [Abstract][Full Text] [Related]
8. Primary care faecal calprotectin testing in children with suspected inflammatory bowel disease: a diagnostic accuracy study.
Walker GJ; Chanchlani N; Thomas A; Lin S; Moore L; Heerasing NM; Hendy P; Abdelrahim M; Mole S; Perry MH; Mcdonald TJ; Bewshea CM; Hart JW; Russell RK; Ahmad T; Goodhand JR; Kennedy NA
Arch Dis Child; 2020 Oct; 105(10):957-963. PubMed ID: 32424002
[TBL] [Abstract][Full Text] [Related]
9. Noninvasive testing in the management of children with suspected inflammatory bowel disease.
Dilillo D; Zuccotti GV; Galli E; Meneghin F; Dell'Era A; Penagini F; Colella G; Lewindon P; Carmagnola S; Farina E; Ardizzone S; Maconi G
Scand J Gastroenterol; 2019 May; 54(5):586-591. PubMed ID: 31032665
[No Abstract] [Full Text] [Related]
10. Faecal calprotectin effectively excludes inflammatory bowel disease in 789 symptomatic young adults with/without alarm symptoms: a prospective UK primary care cohort study.
Walker GJ; Moore L; Heerasing N; Hendy P; Perry MH; McDonald TJ; Debenham T; Bethune R; Bewshea C; Hyde C; Heap GA; Singh A; Calvert C; Kennedy NA; Goodhand JR; Ahmad T
Aliment Pharmacol Ther; 2018 Apr; 47(8):1103-1116. PubMed ID: 29508423
[TBL] [Abstract][Full Text] [Related]
11. Rapid fecal calprotectin testing to assess for endoscopic disease activity in inflammatory bowel disease: A diagnostic cohort study.
Kwapisz L; Mosli M; Chande N; Yan B; Beaton M; Micsko J; Mennill PW; Barnett W; Bax K; Ponich T; Howard J; Tirolese A; Lannigan R; Gregor J
Saudi J Gastroenterol; 2015; 21(6):360-6. PubMed ID: 26655130
[TBL] [Abstract][Full Text] [Related]
12. Fecal calprotectin remains high during glucocorticoid therapy in children with inflammatory bowel disease.
Kolho KL; Raivio T; Lindahl H; Savilahti E
Scand J Gastroenterol; 2006 Jun; 41(6):720-5. PubMed ID: 16716972
[TBL] [Abstract][Full Text] [Related]
13. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
Langhorst J; Elsenbruch S; Koelzer J; Rueffer A; Michalsen A; Dobos GJ
Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a faecal calprotectin care pathway for use in primary care.
Turvill J; O'Connell S; Brooks A; Bradley-Wood K; Laing J; Thiagarajan S; Hammond D; Turnock D; Jones A; Sood R; Ford A
Prim Health Care Res Dev; 2016 Sep; 17(5):428-36. PubMed ID: 26899214
[TBL] [Abstract][Full Text] [Related]
15. Rapid fecal calprotectin level assessment and the SIBDQ score can accurately detect active mucosal inflammation in IBD patients in clinical remission: a prospective study.
Voiosu T; Benguş A; Dinu R; Voiosu AM; Bălănescu P; Băicuş C; Diculescu M; Voiosu R; Mateescu B
J Gastrointestin Liver Dis; 2014 Sep; 23(3):273-8. PubMed ID: 25267955
[TBL] [Abstract][Full Text] [Related]
16. FOCUS: Future of fecal calprotectin utility study in inflammatory bowel disease.
Rosenfeld G; Greenup AJ; Round A; Takach O; Halparin L; Saadeddin A; Ho JK; Lee T; Enns R; Bressler B
World J Gastroenterol; 2016 Sep; 22(36):8211-8. PubMed ID: 27688663
[TBL] [Abstract][Full Text] [Related]
17. Fecal calprotectin and C-reactive protein are associated with positive findings in capsule endoscopy in suspected small bowel Crohn's disease.
Egea Valenzuela J; Pereñíguez López A; Pérez Fernández V; Alberca de Las Parras F; Carballo Álvarez F
Rev Esp Enferm Dig; 2016 Jul; 108(7):394-400. PubMed ID: 27312194
[TBL] [Abstract][Full Text] [Related]
18. Fecal calprotectin as a marker of the severity of mucosal inflammation in children with inflammatory bowel disease.
Dolinšek J; Rižnik P; Sabath L; Mičetić-Turk D
Wien Klin Wochenschr; 2016 Apr; 128(7-8):253-9. PubMed ID: 26659704
[TBL] [Abstract][Full Text] [Related]
19. Avoid Endoscopy in Children With Suspected Inflammatory Bowel Disease Who Have Normal Calprotectin Levels.
Heida A; Holtman GA; Lisman-van Leeuwen Y; Berger MY; van Rheenen PF
J Pediatr Gastroenterol Nutr; 2016 Jan; 62(1):47-9. PubMed ID: 26252922
[TBL] [Abstract][Full Text] [Related]
20. Guidance on the interpretation of faecal calprotectin levels in children.
Orfei M; Gasparetto M; Hensel KO; Zellweger F; Heuschkel RB; Zilbauer M
PLoS One; 2021; 16(2):e0246091. PubMed ID: 33571226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
